Seegene

Seegene, Inc. is molecular diagnostic (MoDx) company that has been turning dreams of molecular diagnostic fields into reality through its pioneering R & D activities and novel technologies. Found in Seoul, Korea in 2000 and with having subsidiary in Rockville, MD, U.S.A., Seegene, Inc. has continued to develop innovative technology platforms, ACP™ (Annealing Control Primer), DPO™ (Dual Priming Oligonucleotide), and READ™ (Real Amplicon Detection) and stretch out globally to better respond to the needs of its valued customers. With these cutting-edge MoDx technologies applied to diagnostic kits and various practical approaches, Seegene has enhanced the sensitivity and specificity of PCR (polymerase chain reaction) up to unprecedented level. This advance enables Seegene, Inc. to provide multiplex PCR products by which multiple target genes of pathogens can be simultaneously detected, saving testing time and cost. Seegene, Inc. will continue to set new standards in MoDx and provide foundation for innovations to come.

Coventional PCR: Conventional size analysis for bands with Electrophoresis method Automated detection with Automatic Capillary Electrophoresis (ACE) More multiplicity test than current Real-time PCR platform Various test menu with Seeplex products

Seeplex workflow

• Automated Detection with Automatic Capillary Electrophoresis (ACE)
• → Focus on LC-DX ( Caliper / USA )
• PCR Amplification with SeeAmp
• Dedicated software for IVD : Seegene Viewer
• Bands size analysis for multiplex
• Similar test procedure as current Agarose-Gel electrophoresis

http://www.seegene.com